372
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder

, , , &
Pages 999-1005 | Received 07 May 2018, Accepted 21 Aug 2018, Published online: 07 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now

Articles from other publishers (2)

Ali Caykoylu, Ersin Hatice Karslioglu, Nese Burcu Bal & Cagla Kocberber. (2022) When and why aripiprazole causes extrapyramidal side effects: Three cases and mini review. Psychiatry Research Case Reports 1:2, pages 100066.
Crossref
Marianna Gajda, Renata Rybakiewicz, Maciej Cieplak, Teresa Żołek, Dorota Maciejewska, Edyta Gilant, Piotr J. Rudzki, Katarzyna Grab, Andrzej Kutner, Paweł Borowicz, Wlodzimierz Kutner & Krzysztof R. Noworyta. (2020) Low-oxidation-potential thiophene-carbazole monomers for electro-oxidative molecular imprinting: Selective chemosensing of aripiprazole. Biosensors and Bioelectronics 169, pages 112589.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.